fbpx

Clearly a Top Stock

Last week, Nu Skin (NUS) upped next quarter’s and 2013’s estimates in a big-league way. NUS popped on the news, jumping from $66 to $79 on the day. Now this is clearly a top stock to own, if you’re already in. Let’s see what the stock looks like now and if this is still a good time to invest.

One Year Chart

NUS_2013_Q2The data in these charts and tables is as of May 6th, when NUS was $59 a share.

The big change in this chart (besides the fact NUS is $79 not $59) is 2013 estimates of $4.29 shown here have now been upped by management to $4.85 – $5.00. The company made $3.52 last year, so if we assume NUS will make $5,  profit growth will rise around 50% this year — this is clearly a top-stock.

NxtQtr’s estimate also increased from $0.96 vs. $0.94 (a year ago) = +2%% to $1.20 vs. $0.94 = +27%. So next quarter increased by 24 cents, but 2013 esimates increased around 70 cents total. This means more good news for the next three quarters.

 

Fair Value

NUS_2013_Q2_FVIn this Fair Value table I put a 15 P/E on NUS and obviously that’s too low (and this estimate of $4.29 is way off).  Today the $79 quote means NUS is selling for 16 times earnings.

On a historical basis, the stock had a P/E of between 21 and 35 during the years 2004 through 2007. During 2008-2011 the stock had annual median P/Es between 13 and 15. Nu Skin often gets a lower P/E because the company pays its employees similar to a pyramid scheme. Right now the stock is hot because profits are hot, and fast money investors have accumulated shares (greed over fear).

If we put a 20 P/E on next year’s new estimate of $5.61 we get a $112 price target, 42% higher than today. This seems realistic given the momentum the stock and profit estimates have. If the stock just gets a 15 P/E then we are looking at an $85 stock, less than 10% upside from the current $79 price.

Sharek’s Take

Nu Skin clearly deserves to be a hot stock, and I feel it still has upside even after the move from $59 to $79. Investors who are short term can buy in now as a momentum play, but I would rather wait for a better entry point. NUS is at the top of my radar.

View the Earnings Table here.
View the Ten Year Chart here.

Leave a Comment

Your email address will not be published. Required fields are marked *

Not a member? Sign up here for $25 a month.